NCT03065166

Brief Summary

This study assesses the acute effects of dried Cabernet grape intake on vascular function and platelet reactivity in postmenopausal women. Previous studies from this lab and others have demonstrated acute effects on vascular function and platelet reactivity from phenolic-rich food sources. Postmenopausal women are suggested as the study group, as they are likely to have compromised vascular function due to the loss of protective estrogen, and have been the study group for past and present research projects in this lab.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 27, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
Last Updated

October 4, 2017

Status Verified

October 1, 2017

Enrollment Period

7 months

First QC Date

February 14, 2017

Last Update Submit

October 3, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Postprandial Micro-vascular Function

    To determine whether an acute intake of dried Cabernet grapes will improve vascular function, as measured using peripheral artery tonometry (PAT).

    Baseline and 2-hour measures on day 0 and day 7.

Secondary Outcomes (6)

  • Platelet Aggregation

    Baseline and 2-hour measures on day 0 and day 7.

  • Nitrate/Nitrite

    Baseline and 2-hour measures on day 0 and day 7.

  • Baseline Complete Metabolic Panel

    Baseline measures on day 0 and day 7.

  • Postprandial Complete Metabolic Panel

    2-hour measures on day 0 and day 7.

  • Body Weight

    Baseline measure on day 0 and day 7.

  • +1 more secondary outcomes

Study Arms (2)

Raisin Treatment

EXPERIMENTAL

3.2 ounces of dried Cabernet wine grapes.

Other: Raisin TreatmentOther: Bagel Control

Bagel Control

OTHER

One 95g whole wheat bagel.

Other: Raisin TreatmentOther: Bagel Control

Interventions

Subjects will consume 3.2oz of dried Cabernet grapes during a single intervention time point.

Bagel ControlRaisin Treatment

Subjects will consume 95g of whole wheat bagel during a single intervention time point.

Bagel ControlRaisin Treatment

Eligibility Criteria

Age50 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Postmenopausal female: 50-70 years
  • Women: lack of menses for at least one year and FSH 23-116.3 mlU/mL
  • Subject is willing and able to comply with the study protocols.
  • Subject is willing to participate in all study procedures
  • BMI 25.0 - 40 kg/m2
  • Weight ≥ 110 pounds

You may not qualify if:

  • BMI ≥ 40 kg/m2
  • Dislike or allergy for grape products and raisins
  • Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
  • Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
  • Alcohol consumption \> 3 drinks/week (i.e. 1 bottle of beer, 1 glass of wine, and 1 shot of hard liquor)
  • Fruit consumption ≥ 2 cups/day
  • Vegetable consumption ≥ 3 cups/day for females
  • Fatty Fish ≥ 3 times/week
  • Coffee/tea ≥ 3 cups/day
  • Dark chocolate ≥ 3 oz/day
  • Self-reported restriction of physical activity due to a chronic health condition
  • Self-reported chronic/routine high intensity exercise
  • Self-reported diabetes
  • Blood pressure ≥ 140/90 mm Hg
  • Self-reported renal or liver disease
  • +18 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ragle Human Nutrition Center

Davis, California, 95616, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2017

First Posted

February 27, 2017

Study Start

September 1, 2016

Primary Completion

April 1, 2017

Study Completion

July 1, 2017

Last Updated

October 4, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations